Impact of patient and navigator race and language concordance on care after cancer screening abnormalities.
Impact of patient and navigator race and language concordance on care after cancer screening abnormalities.
复制标题
DOI:
10.1002/cncr.29221
复制
发表时间:
2015-05-01
期刊:
影响因子:
6.2
通讯作者:
Freund, Karen M.
中科院分区:
文献类型:
--
作者:
Charlot, Marjory;Santana, M. Christina;Chen, Clara A.;Bak, Sharon;Heeren, Timothy C.;Battaglia, Tracy A.;Egan, A. Patrick;Kalish, Richard;Freund, Karen M.
Patient navigation improves timely diagnosis of cancer among minorities but little is known about the effect of patient and navigator race and language concordance on health outcomes. We conducted an investigation of patient and navigator race and language concordance on time to diagnosis of cancer screening abnormalities among participants of the Boston Patient Navigation Research Program, a clinical effectiveness trial for women with breast or cervical cancer screening abnormalities identified January 1, 2007 to December 31, 2008. Hazard ratio and 95% confidence intervals were estimated using proportional hazards regression adjusting for clinical and demographic factors. There were a total of 1257 women with either breast (n= 655) or cervical (n=602) cancer screening abnormalities and 56% were non-White. Language concordance was associated with timelier resolution in all patients in the cervical group in the first 90 days, aHR of 1.46 (95% CI: 1.18, 1.80), and specifically for Spanish speakers in the first 90 days, aHR of 1.43 (95% CI: 1.10, 1.84), with no difference after 90 days or for women with breast cancer screening abnormalities. Race concordance was associated with significant decreases in time to diagnosis for minority women with breast and cervical cancer screening abnormalities in analyses stratified by race with no difference found in analyses including all women. Patient-navigator race and language concordance improves timeliness of care in a minority population. Patient navigators that are diverse by race/ethnicity and multilingual may help address barriers to care and improve cancer outcomes for low-income minorities.
登录
查看更多内容
影响因子:
3.1
作者:
Meghani SH;Brooks JM;Gipson-Jones T;Waite R;Whitfield-Harris L;Deatrick JA
通讯作者:
Deatrick JA
影响因子:
6.2
作者:
Natale-Pereira A;Enard KR;Nevarez L;Jones LA
通讯作者:
Jones LA
DOI:
10.1158/1055-9965.epi-12-0532
发表时间:
2012-10
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Battaglia TA;Bak SM;Heeren T;Chen CA;Kalish R;Tringale S;Taylor JO;Lottero B;Egan AP;Thakrar N;Freund KM
通讯作者:
Freund KM
影响因子:
12.7
作者:
Richardson, Lisa C.;Royalty, Janet;Benard, Vicki B.
通讯作者:
Benard, Vicki B.
影响因子:
3.8
作者:
LaVeist, TA;Nuru-Jeter, A;Jones, KE
通讯作者:
Jones, KE